Description

Sutinat 50mg Capsules contain Sunitinib Malate, a tyrosine kinase inhibitor. Doctors use this medication to treat advanced renal cell carcinoma (RCC) and gastrointestinal stromal tumors (GIST) after disease progression or intolerance to imatinib. Furthermore, it has approval for pancreatic neuroendocrine tumors (pNET) in patients with unresectable, locally advanced, or metastatic disease.

Usage and Administration

Sunitinib works by blocking multiple receptor tyrosine kinases (RTKs) involved in tumor growth, angiogenesis, and metastatic progression. Patients take the medication orally, once daily, in treatment cycles (typically 4 weeks on treatment followed by 2 weeks off). A healthcare provider determines dosing and duration based on clinical response and tolerability.

Manufacturing and Safety

Natco Pharma Ltd. manufactures Sutinat Sunitinib 50mg Capsules. Common side effects include fatigue, hypertension, hand-foot syndrome, and gastrointestinal disturbances. Doctors should regularly monitor blood pressure, complete blood count, and liver function during treatment.

Availability and Purchase

Genetec Lifesciences makes Sutinat 50mg Capsules available. To place an order or request a quote, contact us directly. We ensure that we source all products from verified and authorized vendors.

Disclaimer

Product information mentioned on this site is for informative purposes only. The product image belongs to its respective company. Genetec Lifesciences acts as a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or its authorized vendors.